LAM561 With RT and TMZ for Adults With Glioblastoma
Clinical trial NCT04250922 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04250922
- Sponsor
- Laminar Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2026-01-15
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.